CTP Chair's decision, in the Annual Report, to not discuss the overwhelmingly dominant event this year - the SOA - is rediculous. Up to AU$3 million was spent marketing the SOA to sharehoders with profound conviction the demise of the company in the hands of 8500 small shareholders was imminent. After defeat of the SOA Chair and M.D. now assert CTP is poised for tremendous future. Chair's ducking,weaving,denial on this is absurd. Disclosure similar to a 'Truth and Reconciliation " process is required now by the Chair and M.D. CTP continues its clumsy,irregular,episodic,sub-par attention to shareholder communication ; the relationship with shareholders seems to be an afterthought to everything and everybody else. The company's changing nature and its relationship with shareholders requires people with higher level skills. Its time for the Chair and M.D. to leave. I will vote against re-elections and the rumuneration report.
- Forums
- ASX - By Stock
- truth and reconciliation ?
CTP
central petroleum limited
Add to My Watchlist
1.85%
!
5.5¢

CTP Chair's decision, in the Annual Report, to not discuss the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $40.98M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.4¢ | $91.62K | 1.696M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 6030 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 0.054 |
1 | 100000 | 0.053 |
3 | 719000 | 0.052 |
1 | 800000 | 0.051 |
2 | 39000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 6030 | 1 |
0.059 | 379120 | 4 |
0.060 | 160000 | 3 |
0.061 | 100000 | 1 |
0.067 | 149268 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online